Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- PMID: 35004789
- PMCID: PMC8727528
- DOI: 10.3389/fmed.2021.811570
Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Keywords: Stevens-Johnson Syndrome (SJS); human leukocyte antigen (HLA); international collaboration; severe ocular complications (SOC); toxic epidermal necrolysis (TEN).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
References
-
- Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, et al. Acute and chronic ophthalmic involvement in stevens-johnson syndrome/toxic epidermal necrolysis - a comprehensive review and guide to therapy. II. ophthalmic disease. Ocul Surf. (2016) 14:168–88. 10.1016/j.jtos.2016.02.001 - DOI - PubMed
-
- Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. (2008) 128:35–44. 10.1038/sj.jid.5701033 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
